RT Journal Article
SR Electronic
T1 Delayed CT metrizamide enhancement of syringomyelia secondary to tumor.
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 73
OP 78
VO 4
IS 1
A1 S Kan
A1 A J Fox
A1 F Viñuela
A1 H J Barnett
A1 S J Peerless
YR 1983
UL http://www.ajnr.org/content/4/1/73.abstract
AB Six cases of syringomyelia associated with intramedullary tumor were examined by metrizamide myelography and delayed computed tomography. All cases showed opacification of syringomyelic cavities 7-24 hr after myelography. This finding suggests that metrizamide can pass through the cord substance from the subarachnoid space into a syrinx cavity in noncommunicating types of syringomyelia. It supports the theory of transneural passage of fluid as part of the origin of such cavities. These cases also support the thesis that, in patients with cord cavities, tumor can be excluded only if the cavity is demonstrated within all areas of cord enlargement.